Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: RANDOMIZED PHASE 2 STUDY TO ASSESS SAFETY AND EFFICACY OF LOW-DOSE (LD) ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS: INTERIM SAFETY ANALYSIS
Title:
Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: RANDOMIZED PHASE 2 STUDY TO ASSESS SAFETY AND EFFICACY OF LOW-DOSE (LD) ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS: INTERIM SAFETY ANALYSIS
Author:
Garcia-Manero, G. Bachiashvili, K. Griffiths, E. Traer, E. Saini, L. Amin, H. Zeidan, A. Mohan, S. Lübbert, M. Maness, L. Foran, J. Selleslag, D. Xicoy, B. Pollyea, D. Sallman, D. Al-Kali, A. Berdeja, J. Al-Ali, H. Zhu, N. Lopez, P. Font Sanz, G. Santini, V. Yimer, H. Cripe, L. Priego, V. Odenike, O. Heyrman, B. Valcárcel, D. Vachhani, P. Sano, Y. Mirakhur, B. Oganesian, A. Keer, H. Yacoub, A.